Healthcare provider profile · identity verified

Rene E Hernandez Cordero, MD

General Practice · MOCA, PR · NPI 1356301444

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	403	110
Losartan Potassium	Losartan Potassium	319	84
Famotidine	Famotidine	249	73
Amlodipine Besylate	Amlodipine Besylate	229	56
Metformin Hcl	Metformin Hcl	174	48
Simvastatin	Simvastatin	173	49
Levothyroxine Sodium	Levothyroxine Sodium	154	44
Lisinopril	Lisinopril	138	39
Omeprazole	Omeprazole	133	35
Glimepiride	Glimepiride	125	34
Clonazepam	Clonazepam	113	14
Gabapentin	Gabapentin	105	33
Synthroid	Levothyroxine Sodium	95	22
Metoprolol Succinate	Metoprolol Succinate	87	26
Meloxicam	Meloxicam	86	62
Hydrochlorothiazide	Hydrochlorothiazide	83	21
Januvia	Sitagliptin Phosphate	82	18
Pantoprazole Sodium	Pantoprazole Sodium	81	15
Rosuvastatin Calcium	Rosuvastatin Calcium	81	28
Alendronate Sodium	Alendronate Sodium	75	21
Lorazepam	Lorazepam	71	15
Enalapril Maleate	Enalapril Maleate	56	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	47	25
Buspirone Hcl	Buspirone Hcl	46	15
Montelukast Sodium	Montelukast Sodium	46	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	40
Dexamethasone	Dexamethasone	44	29
Prednisone	Prednisone	41	24
Tamsulosin Hcl	Tamsulosin Hcl	40	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	12
Fluoxetine Hcl	Fluoxetine Hcl	36	14
Temazepam	Temazepam	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Finasteride	Finasteride	33	11
Nateglinide	Nateglinide	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Etodolac	Etodolac	31	21
Meclizine Hcl	Meclizine Hcl	26	14
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Valsartan	Valsartan	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Glipizide	Glipizide	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Cilostazol	Cilostazol	22	suppressed
Insulin Glargine	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Atenolol	Atenolol	20	suppressed
Azithromycin	Azithromycin	20	19
Doxycycline Hyclate	Doxycycline Hyclate	20	19
Humulin N	Insulin Nph Human Isophane	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Baclofen	Baclofen	16	16
Clorazepate Dipotassium	Clorazepate Dipotassium	16	suppressed
Diclofenac Potassium	Diclofenac Potassium	16	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	16	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Cefadroxil	Cefadroxil	14	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Eliquis	Apixaban	14	suppressed
Levofloxacin	Levofloxacin	14	12
Pregabalin	Pregabalin	14	suppressed
Sulindac	Sulindac	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Glyxambi	Empagliflozin/Linagliptin	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error